AASLD	American Association for the Study of Liver Diseases
AFP	alpha-fetoprotein
ALBI	Albumin-Bilirubin Grade
ALD	alcoholic liver disease
ALPPS	Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy
ASA	American Society of Anesthesiologists
BCLC	Barcelona Clinic Liver Cancer
CE	contrast enhanced
CIS	Carcinoma in situ
CLD	chronical liver disease
CP	Child Pugh
CT	computed tomography
ECD	extended criteria donor
ECOG	Eastern Co-operative of Oncology Group
ESLD	end-stage liver disease
FLR	future liver remnant
FLRF	future liver remnant function
HBV	hepatitis B virus
HCC	hepatocellular carcinoma
HCV	hepatitis C virus
HIFU	high-intensity focused ultrasound
ICG	indocyanine green
IRE	irreversible electroporation
ITA.LI.CA.	Italian Liver Cancer database
LDLT	living donor liver transplantation
LiMAx	Liver Maximum Capacity Test
LR	liver resection
MELD	Model for End-stage Liver Disease
MRI	magnetic resonance imaging
MWA	microwave ablation
NAFLD	non-alcoholic fatty liver disease
OLT	orthotopic liver transplantation
OS	overall survival
PEI	percutaneous ethanol injection
PFS	progression-free survival
PST	performance status
PVE	portal vein embolization
RCT	randomized controlled trial
RFA	radiofrequency ablation
SBRT	stereotactic body radiotherapy
TACE	trans-arterial chemoembolization
TTP	time to progression
UCSF	University of California San Francisco
VEGF	vascular endothelial growth factor
VEGFR	vascular endothelial growth factor receptor
Y-90	trans-arterial radioembolization with Y-90